Background: Vitamin D can stall hyper-inflammatory responses, and there are mechanistic reasons for the positive effects of vitamin D in COVID-19 patients.
Objectives: Therefore, this study aimed to evaluate the effect of a single high dose of vitamin D on inflammatory markers in critical patients with COVID-19.
Design and patients: A single center, double-blind, randomized clinical trial was conducted on 61 patients with COVID-19 admitted to the intensive care units. The intervention and placebo groups received a dose of 300,000 IU vitamin D intramuscularly and identical placebo respectively. Patients were followed up for one week. Lactate Dehydrogenase (LDH) (IU/ml), C-reactive protein (CRP) (mg/L), interleukin-6 (IL-6) (Pg/L), lymphocyte, neutrophil, and neutrophil/lymphocyte (N/L) ratios were checked at the beginning and 7 th day of the study.
Key results: A total of 44 patients with COVID-19 have completed this trial with vitamin D insufficiency in the baseline. The lymphocyte level increased while LDH (IU/ml), neutrophil level, and N/L ratio decreased after intervention with a high vitamin D dose, which was insignificant. The CRP (mg/L) and IL-6 (Pg/L) were significantly reduced after high-dose vitamin D intervention.
Conclusions: Based on the results, the effect of high doses of vitamin D on inflammatory indices was significant in patients with COVID-19 hospitalized in the ICU.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.